A national benchmarking survey to explore the use of dose error reduction software in adult intensive care units (ICUs)

Key Points

• Inconsistent approaches to governance oversight may contribute to variability in patient safety.
• The lack of standardized settings for propofol impacts its safe use in intensive care units across England.
• Observational analysis across multiple ICUs highlights the need for further exploration of DERS significance.
• Understanding the variability in DERS could improve governance and patient outcomes in intensive care settings.